Back
Sonnet BioTherapeutics Holdings Stock Price Chart
Better Than Oil Stocks
CLICK HERE TO FIND OUT MORE
Sell
6
SONN
Sonnet BioTherapeutics Holdings
Last Price:
1.83
Seasonality Move:
-3.96%
7 Day Trial
ALL ACCESS PASS
$
7
Zero Day Options Trade LIVE Tuesday at 2 p.m. ET!
Discover The Zero Day Loophole (BEFORE Tues at 2 p.m. ET!)- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SONN is experiencing selling pressure, which indicates risk of future bearish movement.
Sonnet BioTherapeutics Holdings Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.99 | Sell |
| 20-day SMA: | 2.5 | Sell |
| 50-day SMA: | 3.85 | Sell |
| 200-day SMA: | 9.03 | Sell |
| 8-day EMA: | 2.04 | Sell |
| 20-day EMA: | 2.54 | Sell |
| 50-day EMA: | 3.69 | Sell |
| 200-day EMA: | 14.76 | Sell |
Sonnet BioTherapeutics Holdings Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.59 | Sell |
| Relative Strength Index (14 RSI): | 25.75 | Sell |
| Chaikin Money Flow: | -195192 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (2.13 - 3.19) | Sell |
| Bollinger Bands (100): | (3.46 - 6.78) | Sell |
Sonnet BioTherapeutics Holdings Technical Analysis
| Nov 29 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 6 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 29 | 02 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | 12 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Sonnet BioTherapeutics Holdings Stock
Is Sonnet BioTherapeutics Holdings Stock a Buy?
- Sonnet BioTherapeutics Holdings share price is 1.77 while SONN 8-day simple moving average is 1.99, which is a Sell signal.
- The stock price of SONN is 1.77 while Sonnet BioTherapeutics Holdings 20-day SMA is 2.50, which makes it a Sell.
- Sonnet BioTherapeutics Holdings 50-day simple moving average is 3.85 while SONN share price is 1.77, making it a Sell technically.
- SONN stock price is 1.77 and Sonnet BioTherapeutics Holdings 200-day simple moving average is 9.03, creating a Sell signal.
SONN Technical Analysis vs Fundamental Analysis
Sell
6
Sonnet BioTherapeutics Holdings (SONN)
is a Sell
Is Sonnet BioTherapeutics Holdings a Buy or a Sell?
-
Sonnet BioTherapeutics Holdings stock is rated a Sell
The current Sonnet BioTherapeutics Holdings [SONN] share price is $1.77. The Score for SONN is 6, which is 88% below its historic median score of 50, and infers higher risk than normal.
Sonnet BioTherapeutics Holdings Stock Info
Market Cap:
1.15M
Price in USD:
1.77
Share Volume:
351.35K
Sonnet BioTherapeutics Holdings 52-Week Range
52-Week High:
18.72
52-Week Low:
1.66
Sell
6
Sonnet BioTherapeutics Holdings (SONN)
is a Sell
Sonnet BioTherapeutics Holdings Share Price Forecast
-
What is the Sonnet BioTherapeutics Holdings stock price today?
The Sonnet BioTherapeutics Holdings stock price is 1.77 USD today. -
Will SONN stock go up or go down?
Sonnet BioTherapeutics Holdings> share price is forecast to RISE/FALL based on technical indicators -
Is Sonnet BioTherapeutics Holdings overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Sonnet BioTherapeutics Holdings is overvalued.
Is Sonnet BioTherapeutics Holdings Stock a Buy?
- Sonnet BioTherapeutics Holdings share price is 1.77 while SONN 8-day exponential moving average is 2.04, which is a Sell signal.
- The stock price of SONN is 1.77 while Sonnet BioTherapeutics Holdings 20-day EMA is 2.54, which makes it a Sell.
- Sonnet BioTherapeutics Holdings 50-day exponential moving average is 3.69 while SONN share price is 1.77, making it a Sell technically.
- SONN stock price is 1.77 and Sonnet BioTherapeutics Holdings 200-day simple moving average is 14.76, creating a Sell signal.
Fundamental Analysis of Sonnet BioTherapeutics Holdings
Is Sonnet BioTherapeutics Holdings a good investment?
- Analysts estimate an earnings increase this quarter of $5.61 per share, a decrease next quarter of $0.00 per share, an increase this year of $244.56 per share, and an increase next year of $11.01 per share.
Technical Analysis of Sonnet BioTherapeutics Holdings
Should I short Sonnet BioTherapeutics Holdings stock?
- SONN Moving Average Covergence Divergence (MACD) indicator is -0.59, suggesting Sonnet BioTherapeutics Holdings is a Sell
- Sonnet BioTherapeutics Holdings Relative Strength Index (RSI) is 25.75, which suggest Sonnet BioTherapeutics Holdings is oversold
- The Bollinger Bands (25) for Sonnet BioTherapeutics Holdings is (2.13 - 3.19), which suggest Sonnet BioTherapeutics Holdings is a Sell
- The Bollinger Bands (100) for Sonnet BioTherapeutics Holdings is (3.46 - 6.78), which suggest Sonnet BioTherapeutics Holdings is a Sell
* Sonnet BioTherapeutics Holdings stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.